New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:25 EDTDRRX, DRRX, PCRX, PCRXSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
07:27 EDTPCRXPacira price target lowered to $72 from $81 at Jefferies
Subscribe for More Information
July 17, 2015
13:31 EDTDRRXDURECT downgraded to Hold from Buy at Stifel
July 15, 2015
08:07 EDTPCRXPacira, Aratana announce 'positive' pivotal results for AT-003 for dogs
Subscribe for More Information
07:29 EDTPCRXAmerican Orthopaedic Foot & Ankle Society to hold annual meeting
Subscribe for More Information
July 14, 2015
16:21 EDTPCRXAratana Therapeutics reports 'positive results' from pivotal study of AT-003
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use